Edward Libby, M.D.
Edward Libby, M.D.
Associate Professor
Clinical Research Division, Fred Hutch
Dr. Edward N. Libby is a medical oncologist. He specializes in planning and implementing clinical trials to advance the diagnosis and treatment of patients with lymphoma and plasma-cell diseases like multiple myeloma, Waldenstrom macroglobulinemia (a type of non-Hodgkin lymphoma) and amyloidosis.
Other Appointments & Affiliations
Associate Professor, Division of Medical Oncology
University of Washington School of Medicine
Medical Oncologist, Hematologic Malignancies
Seattle Cancer Care Alliance
Education
M.D., University of Texas Health Sciences Center, 1984
B.S., Chemistry, University of Texas, 1979
Current Projects
A Phase 3 Open-Label Randomized Study to Compare the Efficacy and Safety of Rituximab plus Lenalidomide (CC-5013) versus Rituximab plus Chemotherapy Followed by Rituximab in Subjects with Previously Untreated Follicular Lymphoma
Dr. Libby in the News
For the Media
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email media@fredhutch.org or call 206.667.2210